• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.

作者信息

Meade T W, Haines A P, North W R, Chakrabarti R, Howarth D J, Stirling Y

出版信息

Lancet. 1977 Nov 5;2(8045):948-51. doi: 10.1016/s0140-6736(77)90888-1.

DOI:10.1016/s0140-6736(77)90888-1
PMID:72289
Abstract

In 15 women on oral contraceptives containing 30 microgram oestrogen, mean values for factors II, VII, and X, fibrinogen, fibrinolytic activity, antithrombin III, cholesterol, and fasting triglycerides were intermediate between values for 63 women on preparations containing 50 microgram oestrogen and those for 243 premenopausal women not on oral contraceptives. Mean blood-pressure levels, however, were higher in women on 30 microgram than in those on 50 microgram preparations. In 28 women on 50 microgram preparations containing 3 mg or 4 mg norethisterone, mean values of factor VII, fibrinogen, fibrinolytic activity, cholesterol, fasting triglycerides, and systolic blood-pressure were higher than in 15 women whose preparations contained only 1 mg of norethisterone. A less consistent picture was found in women on 30 microgram oestrogen preparations containing either 250 microgram (10 women) or 150 microgram (5 women) d-norgestrel. It is concluded that 30 microgram oestrogen preparations probably result in smaller hemostatic and lipid changes than 50 microgram preparations but that they may have a blood-pressure-raising effect attributable to the particular progestagen, d-norgestrel, used in 30 microgram preparations. The safety of these 30 microgram oestrogen preparations may thus depend partly on the balance between these two sets of effects. It is also concluded that norethisterone may have effects similar to those attributed to oestrogens.

摘要

相似文献

1
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.
Lancet. 1977 Nov 5;2(8045):948-51. doi: 10.1016/s0140-6736(77)90888-1.
2
An epidemiological study of the haemostatic and other effects of oral contraceptives.口服避孕药止血及其他作用的流行病学研究
Br J Haematol. 1976 Nov;34(3):353-64. doi: 10.1111/j.1365-2141.1976.tb03582.x.
3
Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.含30微克和50微克雌激素的口服避孕药的代谢效应。
Med J Aust. 1979 Sep 22;2(6):277-81.
4
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.两种每月注射一次的避孕药(Cyclofem和Mesigyna)与一种口服避孕药(炔诺酮炔雌醇片1/35)对凝血和纤溶作用的比较研究。
Contraception. 2003 Sep;68(3):159-76. doi: 10.1016/s0010-7824(03)00164-1.
5
A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
J Reprod Med. 1983 Jan;28(1 Suppl):92-9.
6
Oral contraceptive estrogen and plasma lipid levels.
Obstet Gynecol. 1978 Oct;52(4):430-5.
7
Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
J Reprod Med. 1983 Jan;28(1 Suppl):85-91.
8
Effects of progestogen oral contraception with norethisterone on blood clotting and platelets.炔诺酮口服孕激素避孕药对血液凝固和血小板的影响。
Br Med J. 1972 Nov 18;4(5837):391-3. doi: 10.1136/bmj.4.5837.391.
9
Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.口服避孕药中合成雌激素和孕激素对胆汁脂质成分的影响。
Gut. 1983 Mar;24(3):253-9. doi: 10.1136/gut.24.3.253.
10
[Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
Arch Sci Med (Torino). 1978 Oct-Dec;135(4):609-17.

引用本文的文献

1
Hypertension Across a Woman's Life Cycle.女性生命周期中的高血压。
Curr Hypertens Rep. 2022 Dec;24(12):723-733. doi: 10.1007/s11906-022-01230-4. Epub 2022 Nov 9.
2
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.使用含有屈螺酮和雌三醇的避孕药的女性,其凝血酶原生成减少。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):135-143. doi: 10.1210/clinem/dgac511.
3
The effect of non-oral hormonal contraceptives on hypertension and blood pressure: A systematic review and meta-analysis.非口服激素类避孕药对高血压和血压的影响:系统评价和荟萃分析。
Physiol Rep. 2022 May;10(9):e15267. doi: 10.14814/phy2.15267.
4
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.复方口服避孕药与静脉血栓栓塞症:风险减轻的回顾与展望。
Front Endocrinol (Lausanne). 2021 Dec 9;12:769187. doi: 10.3389/fendo.2021.769187. eCollection 2021.
5
Hypertension in Women Across the Lifespan.女性全生命周期的高血压。
Curr Atheroscler Rep. 2021 Jun 19;23(8):43. doi: 10.1007/s11883-021-00941-4.
6
Research and progress on ClC‑2 (Review).氯离子通道蛋白2(ClC-2)的研究进展(综述)
Mol Med Rep. 2017 Jul;16(1):11-22. doi: 10.3892/mmr.2017.6600. Epub 2017 May 18.
7
Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.女性激素对血压的影响:潜在机制及临床研究综述
Curr Hypertens Rep. 2003 Dec;5(6):505-12. doi: 10.1007/s11906-003-0059-0.
8
Estrogen modulates ClC-2 chloride channel gene expression in rat kidney.雌激素调节大鼠肾脏中ClC-2氯通道基因的表达。
Pflugers Arch. 2003 Aug;446(5):593-9. doi: 10.1007/s00424-003-1095-y. Epub 2003 Jun 17.
9
Progestogens with antiandrogenic properties.具有抗雄激素特性的孕激素。
Drugs. 2003;63(5):463-92. doi: 10.2165/00003495-200363050-00003.
10
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.口服避孕药使用者的闭塞性血管疾病。流行病学、病理学及发病机制。
Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003.